The method is particularly useful for the detection of antigens associated with breast cancer.Feller, William FKantor, Judith A
The test could help doctors to identify women at high risk of the disease allowing them to take preventive medicines and switch to healthier lifestyles. Researchers have identified a 'genetic switch', carried by one in five women, that doubles their risk of developing breast cancer. Read the...
June 5, 2012 --A simple blood test can help predict the recurrence ofbreast cancer, a new study has found. The question is: Will it save lives? The test detects cancer cells in the blood that have broken free from a tumor in the breast, like seeds that have fallen from...
Signatera™ is a personalized blood test that can detect breast cancer recurrence. Click here to learn more about what it can do for you.
This new technology is one of many efforts to develop a "liquid biopsy" that would use blood tests to find cancer, said Dr. Bill Cance, chief medical and scientific officer with the American Cancer Society. Tumors shed many different types of chemicals and matter into the bloodstrea...
“Syantra’s blood-based test may help improve breast cancer detection for women with high-risk of developing breast cancer, particularly young individuals with genetic predisposition and women with dense breasts or diverse eth...
Cytokine signaling responsiveness measured through a novel blood test may be a key determinant of intratumoral immunosuppressive potential and clinical outcome among patients with newly diagnosed breast cancer, according to study results published in Nat
The findings raise hope that in future, blood tests could be used to provide improved diagnosis and treatment for early-stage breast cancer patients. Currently, diagnosis of early-stage breast cancer often relies on lymph-node removal, which can have unpleasant side-effects. CTC analysis does not...
Media coverage of a complex paper looking at epigenetic markers for breast cancer was widespread but too simplistic. Are the tests accurate and useful, asks Margaret McCartney , and where is the discussion of the potential harms?The Radio 4 Today programme heralded a day of wall to wall ...
"A blood test capable of detecting any of these cancers at an early stage is the over-riding objective of our work," concluded Ms Alfattani. Dr. Iain Frame, CEO of NCRI said: "Early diagnosis using simple, non-invasive ways of detecting the first signs of cancer is a key strategic pr...